MARKET

IRIX

IRIX

IRIDEX
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.21
+0.14
+1.98%
After Hours: 7.21 0 0.00% 16:00 09/17 EDT
OPEN
7.10
PREV CLOSE
7.07
HIGH
7.28
LOW
7.10
VOLUME
43.67K
TURNOVER
--
52 WEEK HIGH
9.71
52 WEEK LOW
1.600
MARKET CAP
114.15M
P/E (TTM)
-37.6895
1D
5D
1M
3M
1Y
5Y
Is IRIDEX (IRIX) Stock a Solid Choice Right Now?
IRIDEX (IRIX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Zacks · 09/08 12:47
Iridex Stock Gains After Posting Highest Sales Since 2007
Benzinga · 08/13 15:37
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Benzinga · 08/13 12:08
BRIEF-Iridex Q2 Revenue Rose 116% To $13.4 Million
reuters.com · 08/12 22:13
Iridex: Q2 Earnings Insights
Shares of Iridex (NASDAQ:IRIX) moved higher by 1.4% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 145.00% over the past year to $0.09, which beat the estimate of ($0.15).
Benzinga · 08/12 21:30
Iridex Q2 EPS $0.09 Beats $(0.15) Estimate, Sales $13.40M Beat $11.61M Estimate
Iridex (NASDAQ:IRIX) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $(0.15) by 160 percent. This is a 145 percent increase over losses of $(0.20) per share from the same
Benzinga · 08/12 21:03
Iridex Announces Second Quarter 2021 Financial Results
Achieved 116% Year-over-Year Revenue Growth and Record Cyclo G6 Probe SalesIncreases Full Year 2021 Guidance MOUNTAIN VIEW, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX) today reported financial results for the second quarter ...
GlobeNewswire · 08/12 20:05
Iridex (IRIX) Reports Q2 Loss, Tops Revenue Estimates
Zacks.com · 08/12 08:57
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of IRIX. Analyze the recent business situations of IRIDEX through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average IRIX stock price target is 10.50 with a high estimate of 11.00 and a low estimate of 10.00.
EPS
Institutional Holdings
Institutions: 44
Institutional Holdings: 5.62M
% Owned: 35.53%
Shares Outstanding: 15.83M
TypeInstitutionsShares
Increased
11
196.53K
New
9
343.35K
Decreased
9
378.92K
Sold Out
6
162.71K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.54%
Healthcare Equipment & Supplies
+0.65%
Key Executives
Non-Executive Chairman/Independent Director
Scott Shuda
President/Chief Executive Officer/Director
David Bruce
Chief Financial Officer
Fuad Ahmad
Chief Operating Officer
Patrick Mercer
Independent Director
Nandini Devi
Independent Director
Robert Grove
Independent Director
Kenneth Ludlum
No Data
About IRIX
IRIDEX Corporation is an ophthalmic medical technology company. The Company is focused on developing and commercializing of products to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, its laser consoles offer, glaucoma product line includes Cyclo G6, Micropulse P3 Probe, G-Probe and G-Probe Illuminate laser system used for the treatment of glaucoma. Medical Retina product line includes IQ 532 and IQ 577 laser photocoagulation systems used for the treatment of diabetic macular edema and other retinal diseases. Surgical Retina line of products includes OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL and OcuLight GLxlaser photocoagulation systems used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments. Its delivery devices offer txcell scanning laser delivery system (TxCell).

Webull offers kinds of IRIDEX Corporation stock information, including NASDAQ:IRIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRIX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IRIX stock methods without spending real money on the virtual paper trading platform.